openPR Logo
Press release

Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026

02-05-2019 08:10 PM CET | Health & Medicine

Press release from: Transparency Market Research

Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026

Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many body fluids during an active infection, including saliva, urine, blood, breast milk, semen, vaginal secretions, and cerebrospinal fluid. It is easily transmitted to others through close physical contact or by contact with infected objects such as diapers or toys. The cytomegalovirus (CMV) test is important as the virus causes significant health problems among the population. In infants, a CMV infection causes serious physical and developmental problems.

Read Report Overview:
https://www.transparencymarketresearch.com/cytomegalovirus-test-market.html

Most newborns (about 90%) who are infected appear healthy at birth but may develop hearing or vision problems, pneumonia, seizures, and/or delayed mental development a few months later. A few babies may be stillborn, while others may have symptoms at birth such as jaundice, anemia, an enlarged spleen or liver, and a small head. CMV test assays aid in the detection of cytomegalovirus. This is likely expand the research capabilities on cytomegalovirus (CMV) drugs and enable new diagnostic and treatment applications for patients. Many research institutes and laboratories are focusing on cytomegalovirus (CMV) tests for the diagnosis of cytomegalovirus through different technologies. Modulation of a unique technology and approach by physicians ensures better functional ability of this test. New developments in pharmological and CMV vaccine therapy approaches allow to image the function of immune system at the cellular and molecular level. This is positively affecting early diagnosis and treatment of diseases.

High prevalence of chronic diseases such as cancer and diabetes , rise in the incidence of congenital CMV, increase in patient awareness about CMV, rise in research and development initiatives, advent of high-throughput screening (HTS) for drug discovery and vaccination, and development in genomic technology are key factors driving the cytomegalovirus (CMV) test market. According to the Centers for Disease Control and Prevention (CDC), about 50% of adults in the U.S. are infected with CMV by the age of 40. Around 90% of babies born with CMV have no symptoms, but 10% to 15% develop hearing loss, normally during their first six months of life. The severity ranges from slight to total hearing loss. Despite the progress in infection rates, CMV testing is also increasing across the globe. An increase in the number of patients with cancer, rise in neonatal births rates, and rapidly increasing awareness about therapeutics and vaccines are projected to fuel the cytomegalovirus (CMV) test market. However, factors such as high cost of diagnosis are expected to hamper the cytomegalovirus (CMV) test market in the coming years.

Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54774

The global cytomegalovirus (CMV) test drugs market can be segmented based on assay type, application, end-user, and region. In terms of assay type, the market can be classified into enzyme-linked immunosorbent assay (ELISA), PCR assays, DNA assay, and others. Based on application, the market can be categorized into DNA probes, monoclonal antibodies, immunoassays, and others. DNA probes is a rapidly expanding segment owing to an increase in the incidence of cancer globally. In terms of end-user, the market can be split into diagnostic laboratories, pathology labs, life sciences and research labs, and others.

In terms of region, the market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global cytomegalovirus (CMV) test market due to an increase in funding for the development of research and health care infrastructure in the region. Rise in the incidence of diseases such as cancer and HIV and early phase diagnosis and treatment of the diseases are driving the biotechnology and research sector. This, in turn, is expected to boost the cytomegalovirus (CMV) test market in North America. Europe is a prominent region of the cytomegalovirus (CMV) test market due to favorable government policies regarding the development of health care infrastructure and diagnostic laboratories.

The market in Asia Pacific is expected to expand at a high growth rate during the forecast period due to a rise in birth rates, changing lifestyle, and increasing awareness among patients about diseases such as cancer and HIV, and rise in per capita expenditure. Additionally, the economic growth in India and China is augmenting health care infrastructure and boosting the expansion of pharmaceutical companies and biotech labs. This is expected to fuel the cytomegalovirus (CMV) test market in Asia Pacific in the near future.

Request Report TOC: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=54774

About Us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: akash.p@tmr.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026 here

News-ID: 1562646 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for CMV

Cytomegalovirus (CMV) Infections Market Massive Growth opportunity Ahead
Introduction Cytomegalovirus (CMV) is a common herpesvirus that affects people worldwide, often remaining latent in the body and reactivating under immunocompromised conditions. While typically asymptomatic in healthy individuals, CMV can cause severe complications in newborns, transplant recipients, and immunocompromised patients, making it a significant global healthcare burden. With increasing awareness, advances in antiviral therapies, vaccines under development, and transplant-related CMV management, the CMV infections market is experiencing strong growth. The integration of
Cytomegalovirus (CMV) Vaccine Market | Exploring Current Trends and Growth Statu …
Cytomegalovirus (CMV) Vaccine Market Outlook and Investment Analysis What is the current outlook for the Cytomegalovirus (CMV) vaccine market? The CMV vaccine market is seeing positive growth due to the increasing prevalence of CMV infections globally, particularly in immunocompromised populations such as organ transplant recipients and HIV patients. Moreover, the growing awareness of CMV's impact on newborns has contributed to the push for preventive vaccines. A few vaccines are in advanced clinical
Global Commercial Cooking Device Market Forecast 2018-2025 CMV Sharper Finish, Q …
Market study on Global Commercial Cooking Device 2018 Research Report presents a professional and complete analysis of Global Commercial Cooking Device Market on the current market situation. Report provides a general overview of the Commercial Cooking Device industry 2018 including definitions, classifications, Commercial Cooking Device market analysis, a wide range of applications and Commercial Cooking Device industry chain structure. The 2018's report on Commercial Cooking Device industry offers the global
Cytomegalovirus (CMV) Market: Size, Status, Opportunity Analysis and Forecasts t …
A new independent 162 page research with title 'Cytomegalovirus (CMV): Opportunity Analysis and Forecasts to 2027' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Atara Bio, Biotest AG, Helocyte, Merck & Co., Novartis, Shire, ViraCyte With n-number of tables and figures examining the Cytomegalovirus (CMV) Market, the research gives
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Opportunity Analy …
Cytomegalovirus (CMV) is a virus that belongs to herpes virus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market - Global Industry …
Cytomegalovirus (CMV) is a virus that belongs to herpesvirus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can be